83_FR_26176 83 FR 26068 - National Heart, Lung, and Blood Institute; Notice of Meeting

83 FR 26068 - National Heart, Lung, and Blood Institute; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 108 (June 5, 2018)

Page Range26068-26069
FR Document2018-11959

Federal Register, Volume 83 Issue 108 (Tuesday, June 5, 2018) 
[Federal Register Volume 83, Number 108 (Tuesday, June 5, 2018)]
[Notices]
[Pages 26068-26069]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-11959]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Sleep Disorders 
Research Advisory Board.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Sleep Disorders Research Advisory Board.
    Date: June 21-22, 2018.
    Time: June 21, 2018, 1:00 p.m. to 5:00 p.m.
    Agenda: Evaluate sleep and circadian research activities; 
discuss plans for the proposed revision of the NIH Sleep Disorders 
Research Plan, and potential opportunities for the inter-agency 
coordination activities.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9112-9116, 6701 Rockledge Drive, Bethesda, MD 20892.

[[Page 26069]]

    Time: June 22, 2017, 8:00 a.m. to 3:00 p.m.
    Agenda: Evaluate sleep and circadian research activities; 
discuss plans for the proposed revision of the NIH Sleep Disorders 
Research Plan, and potential opportunities for the inter-agency 
coordination activities.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9100-9104, 6701 Rockledge Drive, Bethesda, MD 20892.
    Contact Person: Michael J. Twery, Ph.D., Director, National 
Center on Sleep Disorders Research, Division of Lung Diseases, 
National Heart, Lung, and Blood Institute, National Institutes of 
Health, 6701 Rockledge Drive, Suite 10170, Bethesda, MD 20892-7952, 
301-435-0199, [email protected].

    Information is also available on the Institute's/Center's home 
page: https://www.nhlbi.nih.gov/about/committees/sdrab/, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: May 30, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-11959 Filed 6-4-18; 8:45 am]
 BILLING CODE 4140-01-P

26068 Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices Time: 12:00 p.m. to 5:00 p.m. Room 2182 MSC 7818, Bethesda, MD 20892, Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant 301–827–5467, ganesan.ramesh@nih.gov. Rockledge Drive, Bethesda, MD 20892. applications. Name of Committee: Center for Scientific Contact Person: Neerja Kaushik-Basu, Place: National Institutes of Health, 6701 Review Special Emphasis Panel; PAR Panel: Ph.D., Scientific Review Officer, Center for Rockledge Drive, Bethesda, MD 20892 Health Disparities in and Caregiving for Scientific Review, National Institutes of (Virtual Meeting). Alzheimer’s Disease. Health, 6701 Rockledge Drive, Room 3198, Contact Person: Liliana N Berti-Mattera, Date: June 29, 2018. MSC 7808, Bethesda, MD 20892, (301) 435– Ph.D., Scientific Review Officer, Center for Time: 10:00 a.m. to 6:00 p.m. 2306, kaushikbasun@csr.nih.gov. Scientific Review, National Institutes of Agenda: To review and evaluate grant Name of Committee: Center for Scientific Health, 6701 Rockledge Drive, RM 4215, applications. Review Special Emphasis Panel; Member Bethesda, MD 20892, 301–827–7609, Place: National Institutes of Health, 6701 Conflict: Psychosocial Risks and Disease liliana.berti-mattera@nih.gov. Rockledge Drive, Bethesda, MD 20892. Prevention. Name of Committee: Center for Scientific Contact Person: Gabriel B Fosu, Ph.D., Date: July 2, 2018. Review Special Emphasis Panel; Member Scientific Review Officer, Center for Time: 1:00 p.m. to 4:00 p.m. Conflict: Addictions, Depression, Bipolar Scientific Review, National Institutes of Agenda: To review and evaluate grant Disorder, and Schizophrenia. Health, 6701 Rockledge Drive, Room 3108, applications. Date: June 29, 2018. MSC 7808, Bethesda, MD 20892, (301) 435– Place: National Institutes of Health, 6701 Time: 8:00 a.m. to 5:00 p.m. 3562, fosug@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892 Agenda: To review and evaluate grant Name of Committee: Center for Scientific (Virtual Meeting). applications. Review Special Emphasis Panel; Accelerating Contact Person: Weijia Ni, Ph.D., Chief/ Place: National Institutes of Health, 6701 the Pace of Drug Abuse Research Using Scientific Review Officer, Center for Rockledge Drive, Bethesda, MD 20892 Existing Data. Scientific Review, National Institutes of (Virtual Meeting). Date: June 29, 2018. Health, 6701 Rockledge Drive, Room 3100, Contact Person: Kristin Kramer, Ph.D., Time: 11:00 a.m. to 3:00 p.m. MSC 7808, Bethesda, MD 20892, 301–594– Scientific Review Officer, Center for Agenda: To review and evaluate grant 3292, niw@csr.nih.gov. Scientific Review, National Institutes of applications. (Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 5205, Place: National Institutes of Health, 6701 Program Nos. 93.306, Comparative Medicine; MSC 7846, Bethesda, MD 20892, (301) 437– Rockledge Drive, Bethesda, MD 20892 93.333, Clinical Research, 93.306, 93.333, 0911, kramerkm@csr.nih.gov. (Virtual Meeting). 93.337, 93.393–93.396, 93.837–93.844, Name of Committee: Infectious Diseases Contact Person: Kate Fothergill, Ph.D., 93.846–93.878, 93.892, 93.893, National and Microbiology Integrated Review Group; Scientific Review Officer, Center for Institutes of Health, HHS) Drug Discovery and Mechanisms of Scientific Review, National Institutes of Dated: May 30, 2018. Antimicrobial Resistance Study Section. Health, 6701 Rockledge Drive Room 3142, David D. Clary, Date: June 29, 2018. Bethesda, MD 20892, 301–435–2309, fothergillke@mail.nih.gov. Program Analyst, Office of Federal Advisory Time: 8:00 a.m. to 7:00 p.m. Committee Policy. Agenda: To review and evaluate grant Name of Committee: Center for Scientific applications. Review Special Emphasis Panel; PAR 17–199 [FR Doc. 2018–11955 Filed 6–4–18; 8:45 am] Place: Cambria Suites and Hotel, 1 Helen and PAR 17–200: Development of Pediatric BILLING CODE 4140–01–P Heneghan Way, Rockville, MD 20850. Formulations and Drug Delivery Systems. Contact Person: Guangyong Ji, Ph.D., Date: June 29, 2018. Scientific Review Officer, Center for Time: 11:00 a.m. to 4:00 p.m. DEPARTMENT OF HEALTH AND Scientific Review, National Institutes of Agenda: To review and evaluate grant HUMAN SERVICES Health, 6701 Rockledge Drive, Room 3188, applications. MSC 7808, Bethesda, MD 20892, 301–435– Place: National Institutes of Health, 6701 National Institutes of Health 1146, jig@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892 Name of Committee: Infectious Diseases (Telephone Conference Call). National Heart, Lung, and Blood and Microbiology Integrated Review Group; Contact Person: Sharon S Low, Ph.D., Institute; Notice of Meeting Bacterial Pathogenesis Study Section. Scientific Review Officer, Center for Date: June 29, 2018. Scientific Review, National Institutes of Pursuant to section 10(a) of the Time: 8:00 a.m. to 6:00 p.m. Health, 6701 Rockledge Drive, Room 5104, Federal Advisory Committee Act, as Agenda: To review and evaluate grant MSC 5104, Bethesda, MD 20892–5104, 301– amended, notice is hereby given of a applications. 237–1487, lowss@csr.nih.gov. meeting of the Sleep Disorders Research Place: Bethesda North Marriott Hotel & Name of Committee: Center for Scientific Advisory Board. Conference Center. 5701 Marinelli Road, Review Special Emphasis Panel; Small The meeting will be open to the Bethesda, MD 20852. Business: Biomaterials, Delivery, and public, with attendance limited to space Contact Person: Marci Scidmore, Ph.D., Nanotechnology. available. Individuals who plan to Scientific Review Officer, Center for Date: July 2–3, 2018. attend and need special assistance, such Scientific Review, National Institutes of Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 3192, Agenda: To review and evaluate grant as sign language interpretation or other MSC 7808, Bethesda, MD 20892, 301–435– applications. reasonable accommodations, should 1149, marci.scidmore@nih.gov. Place: Ritz-Carlton Hotel, 1700 Tysons notify the Contact Person listed below Name of Committee: Center for Scientific Boulevard, McLean, VA 22102. in advance of the meeting. Review Special Emphasis Panel; Small Contact Person: Nitsa Rosenzweig, Ph.D., Name of Committee: Sleep Disorders Business: Urology and Urogynecology Scientific Review Officer, Center for Research Advisory Board. Application Review. Scientific Review, National Institutes of Date: June 21–22, 2018. Date: June 29, 2018. Health, 6701 Rockledge Drive, Room 4152, Time: June 21, 2018, 1:00 p.m. to 5:00 p.m. Time: 10:00 a.m. to 1:00 p.m. MSC 7760, Bethesda, MD 20892, (301) 404– Agenda: Evaluate sleep and circadian amozie on DSK3GDR082PROD with NOTICES1 Agenda: To review and evaluate grant 7419, rosenzweign@csr.nih.gov. research activities; discuss plans for the applications. Name of Committee: Center for Scientific proposed revision of the NIH Sleep Disorders Place: National Institutes of Health, 6701 Review Special Emphasis Panel; Member Research Plan, and potential opportunities Rockledge Drive, Bethesda, MD 20892 Conflict: Topics in Virology. for the inter-agency coordination activities. (Telephone Conference Call). Date: July 2, 2018. Place: National Institutes of Health, Two Contact Person: Ganesan Ramesh, Ph.D., Time: 9:00 a.m. to 6:30 p.m. Rockledge Center, Conference Room 9112– Center for Scientific Review, National Agenda: To review and evaluate grant 9116, 6701 Rockledge Drive, Bethesda, MD Institutes of Health, 6701 Rockledge Drive, applications. 20892. VerDate Sep<11>2014 20:19 Jun 04, 2018 Jkt 241001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1

Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices 26069 Time: June 22, 2017, 8:00 a.m. to 3:00 p.m. Contact Person: Lilia Topol, Ph.D., Agenda: Discussion on Population Science, Agenda: Evaluate sleep and circadian Scientific Review Officer, Center for Epidemiology and Disparities. research activities; discuss plans for the Scientific Review, National Institutes of Place: Gaithersburg Marriott proposed revision of the NIH Sleep Disorders Health, 6701 Rockledge Drive, Room 6192, Washingtonian Center, Room—To Be Research Plan, and potential opportunities MSC 7804, Bethesda, MD 20892, 301–451– Determined, 9751 Washington Boulevard, for the inter-agency coordination activities. 0131, ltopol@mail.nih.gov. Gaithersburg, MD 20878. Place: National Institutes of Health, Two This notice is being published less than 15 Contact Person: Dr. Deborah Winn, Rockledge Center, Conference Room 9100– days prior to the meeting due to the timing Executive Secretary, NCAB Ad Hoc 9104, 6701 Rockledge Drive, Bethesda, MD limitations imposed by the review and Subcommittee on Population Science, 20892. funding cycle. Epidemiology and Disparities, National Contact Person: Michael J. Twery, Ph.D., (Catalogue of Federal Domestic Assistance Cancer Institute—Shady Grove, National Director, National Center on Sleep Disorders Institutes of Health, 9609 Medical Center Program Nos. 93.306, Comparative Medicine; Research, Division of Lung Diseases, National Drive, Room 4E344, Bethesda, MD 20892, 93.333, Clinical Research, 93.306, 93.333, Heart, Lung, and Blood Institute, National (240) 276–6755, winnde@mail.nih.gov. 93.337, 93.393–93.396, 93.837–93.844, Institutes of Health, 6701 Rockledge Drive, Name of Committee: National Cancer 93.846–93.878, 93.892, 93.893, National Suite 10170, Bethesda, MD 20892–7952, 301– Advisory Board; Ad Hoc Subcommittee on 435–0199, twerym@nhlbi.nih.gov. Institutes of Health, HHS) Global Cancer Research. Information is also available on the Dated: May 30, 2018. Open: June 25, 2018, 7:30 p.m. to 9:00 p.m. Institute’s/Center’s home page: https:// David D. Clary, Agenda: Discussion on Global Cancer www.nhlbi.nih.gov/about/committees/sdrab/, Program Analyst, Office of Federal Advisory Research. where an agenda and any additional Committee Policy. Place: Gaithersburg Marriott information for the meeting will be posted Washingtonian Center, Room—To Be [FR Doc. 2018–11956 Filed 6–4–18; 8:45 am] when available. Determined, 9751 Washington Boulevard, BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance Gaithersburg, MD 20878. Program Nos. 93.233, National Center for Contact Person: Dr. Edward Trimble, Sleep Disorders Research; 93.837, Heart and Executive Secretary, NCAB Ad Hoc Vascular Diseases Research; 93.838, Lung DEPARTMENT OF HEALTH AND Subcommittee on Global Cancer Research, Diseases Research; 93.839, Blood Diseases HUMAN SERVICES National Cancer Institute—Shady Grove, and Resources Research, National Institutes National Institutes of Health, 9609 Medical of Health, HHS) National Institutes of Health Center Drive, Room 3W562, Bethesda, MD Dated: May 30, 2018. 20892, (240) 276–5796, trimblet@ National Cancer Institute; Notice of mail.nih.gov. Michelle D. Trout, Meeting Name of Committee: National Cancer Program Analyst, Office of Federal Advisory Committee Policy. Pursuant to section 10(d) of the Advisory Board and NCI Board of Scientific Advisors. [FR Doc. 2018–11959 Filed 6–4–18; 8:45 am] Federal Advisory Committee Act, as Open: June 26, 2018, 8:30 a.m. to 5:00 p.m. BILLING CODE 4140–01–P amended, notice is hereby given of the Agenda: Joint meeting of the National joint meeting of the National Cancer Cancer Advisory Board and NCI Board of Advisory Board (NCAB) and NCI Board Scientific Advisors, NCI Director’s report and DEPARTMENT OF HEALTH AND of Scientific Advisors (BSA). presentations, NCI Board of Scientific HUMAN SERVICES The meeting will be open to the Advisors Concepts Review. public as indicated below, with Closed: June 26, 2018, 5:00 p.m. to 6:00 National Institutes of Health attendance limited to space available. p.m. Individuals who plan to attend and Agenda: Review of NCAB grant Center For Scientific Review; Notice of applications. Closed Meeting need special assistance, such as sign Place: National Cancer Institute—Shady language interpretation or other Grove 9609, Medical Center Drive, Room Pursuant to section 10(d) of the reasonable accommodations, should TE406 & 408 Rockville, MD 20850. Federal Advisory Committee Act, as notify the Contact Person listed below Contact Person: Paulette S. Gray, Ph.D., amended, notice is hereby given of the in advance of the meeting. The open Director, Division of Extramural Activities, following meeting. session will be videocast and can be National Cancer Institute—Shady Grove, The meeting will be closed to the accessed from the NIH Videocasting and National Institutes of Health, 9609 Medical public in accordance with the Podcasting website (http:// Center Drive, Room 7W444, Bethesda, MD provisions set forth in sections videocast.nih.gov). 20892, 240–276–6340, grayp@mail.nih.gov. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., A portion of the National Cancer Name of Committee: National Cancer as amended. The grant applications and Advisory Board and NCI Board of Scientific Advisory Board meeting will be closed the discussions could disclose Advisors. to the public in accordance with the Open: June 27, 2018, 9:00 a.m. to 12:00 confidential trade secrets or commercial provisions set forth in sections p.m. property such as patentable material, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: Joint meeting of the National and personal information concerning as amended. The grant applications and Cancer Advisory Board and NCI Board of individuals associated with the grant the discussions could disclose Scientific Advisors, NCI Board of Scientific applications, the disclosure of which confidential trade secrets or commercial Advisors Concepts Review. would constitute a clearly unwarranted property such as patentable material, Place: National Cancer Institute—Shady invasion of personal privacy. and personal information concerning Grove 9609 Medical Center Drive, Room TE406 & 408 Rockville, MD 20850. Name of Committee: Center for Scientific individuals associated with the grant Review Special Emphasis Panel; Small Contact Person: Paulette S. Gray, Ph.D., applications, the disclosure of which amozie on DSK3GDR082PROD with NOTICES1 Business: Cancer Drug Development and Director, Division of Extramural Activities, would constitute a clearly unwarranted National Cancer Institute—Shady Grove, Therapeutics. invasion of personal privacy. National Institutes of Health, 9609 Medical Date: June 18–19, 2018. Time: 8:00 a.m. to 5:00 p.m. Name of Committee: National Cancer Center Drive, Room 7W444, Bethesda, MD Agenda: To review and evaluate grant Advisory Board; Ad Hoc Subcommittee on 20892, grayp@mail.nih.gov. applications. Population Science, Epidemiology and Any interested person may file written Place: Residence Inn Bethesda, 7335 Disparities. comments with the committee by forwarding Wisconsin Avenue, Bethesda, MD 20814. Open: June 25, 2018, 5:30 p.m. to 7:00 p.m. the statement to the Contact Person listed on VerDate Sep<11>2014 20:19 Jun 04, 2018 Jkt 241001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1


Document Created: 2018-11-02 11:47:31
Document Modified: 2018-11-02 11:47:31
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 21-22, 2018.
FR Citation83 FR 26068 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR